By suppressing p21 by binding to EZH2, LINC01088 can enhance cell proliferation, ultimately aggravating the tumorigenicity of non-small cell lung cancer (NSCLC) [35]. This evidence concerns the gene EZH2 and non-small cell lung carcinoma.